Risk-Stratified and Response-Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience
Conclusion: The international cooperation made it possible to significantly improve the outcomes of patients with advance disease in Argentina compared with our previous experience (7-PHD-96: COPP–ABV × 6 + IFRT Bulky Disease or PR (20/25 Gy): 5yOS: 85%, 5yEFS: 67%), reduce the number of patients wh...
Saved in:
| Main Authors: | David Veron, Patricia Streitenberger, Mónica Matus, Pedro Negri Aranguren, Alejandra Costa, Daniela Morell, Sergio Terrasa, E. Mauricio Castellanos, Pedro de Alarcon, Eduardo Dibar, Mónica Makiya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/ah/5453729 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benefits of BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) versus ABVD (doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine) in patients with advanced-stage Hodgkin's lymphoma: an analysis of the ECHELON 1 trial by the GATLA group using the Delphi Method
by: Astrid Pavlovsky, et al.
Published: (2024-12-01) -
Non-Hodgkin lymphoma of bone in an HIV-infected patient from Argentina
by: Uriel Sandkovsky, et al.
Published: (2011-09-01) -
Pathobiology of Hodgkin Lymphoma
by: Pier Paolo Piccaluga, et al.
Published: (2011-01-01) -
EBV IN HODGKIN LYMPHOMA
by: Giuseppina Massini, et al.
Published: (2009-11-01) -
EBV IN HODGKIN LYMPHOMA
by: Stefan Hohaus, et al.
Published: (2009-11-01)